+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands)

  • ID: 4040499
  • Report
  • January 2017
  • Region: United Kingdom, Europe, Germany, France, Italy, Netherlands, Norway, Spain, Sweden, Switzerland
  • 120 Pages
  • Renub Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Cervical Cancer Incidence Rate in Europe Was 10.6 Per 100,000 Women Population

Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands) is a 119 Page market research report with 115 Figures and 2 Tables

Cervical cancer is one of the most serious public health issues in Europe. Despite introduction of vaccination in 21 European countries, still more than 24 Thousand women have died from cervical cancer across all over Europe. Cervical cancer incidence rate in Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are top three dominating countries in the Europe cervical cancer market in 2015.

All 9 countries in this report have been studied from 3 viewpoints.

Cervical Cancer Test Market, Population & Mortality:

  • Cervical Cancer Test Population (2008-2020)
    • Pap Smear Test Population & Forecast
    • HPV DNA Test Population & Forecast
  • Cervical Cancer Mortality Population (2001-2011)
  • Cervical Cancer Test Market (2008-2020)
    • Pap Smear Test Market & Forecast
    • HPV DNA Test Market & Forecast

9 Countries studied in the report are as follows:

  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • Sweden
  • Switzerland
  • Norway
  • Netherlands

Data Sources:

  • This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by industry experts.
  • Primary sources include industry surveys and telephone interviews with industry experts.
  • Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary

2. Europe Cervical Cancer Test (Screening) Population & Forecast

3. Europe Cervical Cancer Test (Screening) Market & Forecast
3.1 Europe Cervical Cancer Pap Smear Test (Screening) Market & Forecast
3.2 Europe Cervical Cancer HPV DNA Test (Screening) Market & Forecast

4. Europe Cervical Cancer Test (Screening) Population Share, Market Share & Forecast
4.1 Europe Cervical Cancer Test (Screening) Population Share & Forecast
4.2 Europe Cervical Cancer Test (Screening) Market Share & Forecast
4.3 Europe Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
4.4 Europe Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

5. United Kingdom - Cervical Cancer Test Analysis
5.1 United Kingdom Cervical Cancer Test (Screening) Population
5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast
5.2 United Kingdom Cervical Cancer Deaths
5.3 United Kingdom Cervical Cancer Test (Screening) Analysis
5.3.1 United Kingdom Cervical Cancer Test Market & Forecast
5.3.2 United Kingdom Pap Smear Test Market & Forecast
5.3.3 United Kingdom HPV DNA Test Market & Forecast

6. France - Cervical Cancer Test Analysis
6.1 France Cervical Cancer Test (Screening) Population
6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast
6.2 France Cervical Cancer Mortality
6.3 France Cervical Cancer Test (Screening) Analysis
6.3.1 France Cervical Cancer Test Market & Forecast
6.3.2 France Pap Smear Test Market & Forecast
6.3.3 France HPV DNA Test Market & Forecast

7. Germany - Cervical Cancer Test Analysis
7.1 Germany Cervical Cancer Test (Screening) Population
7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast
7.2 Germany Cervical Cancer Mortality
7.3 Germany Cervical Cancer Test (Screening) Market
7.3.1 Germany Cervical Cancer Test Market & Forecast
7.3.2 Germany Pap Smear Test Market & Forecast
7.3.3 Germany HPV DNA Test Market & Forecast

8. Italy - Cervical Cancer Test Analysis
8.1 Italy Cervical Cancer Test (Screening) Population
8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast
8.2 Italy Cervical Cancer Mortality
8.3 Italy Cervical Cancer Test (Screening) Market
8.3.1 Italy Cervical Cancer Test Market & Forecast
8.3.2 Italy Pap Smear Test Market & Forecast
8.3.3 Italy HPV DNA Test Market & Forecast

9. Spain - Cervical Cancer Test Analysis
9.1 Spain Cervical Cancer Test (Screening) Population
9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast
9.2 Spain Cervical Cancer Mortality
9.3 Spain Cervical Cancer Test (Screening) Market
9.3.1 Spain Cervical Cancer Test Market & Forecast
9.3.2 Spain Pap Smear Test Market & Forecast
9.3.3 Spain HPV DNA Test Market & Forecast

10. Sweden - Cervical Cancer Test Analysis
10.1 Sweden Cervical Cancer Test (Screening) Population
10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast
10.2 Sweden Cervical Cancer Mortality
10.3 Sweden Cervical Cancer Test (Screening) Market
10.3.1 Sweden Cervical Cancer Test Market & Forecast
10.3.2 Sweden Pap Smear Test Market & Forecast
10.3.3 Sweden HPV DNA Test Market & Forecast

11. Switzerland - Cervical Cancer Test Analysis
11.1 Switzerland Cervical Cancer Test (Screening) Population
11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast
11.2 Switzerland Cervical Cancer Mortality
11.3 Switzerland Cervical Cancer Test (Screening) Market
11.3.1 Switzerland Cervical Cancer Test Market & Forecast
11.3.2 Switzerland Pap smear Test Market & Forecast
11.3.3 Switzerland HPV DNA Test Market & Forecast

12. Norway - Cervical Cancer Test Analysis
12.1 Norway Cervical Cancer Test (Screening) Population
12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
12.2 Norway Cervical Cancer Mortality
12.3 Norway Cervical Cancer Test (Screening) Market
12.3.1 Norway Cervical Cancer Test Market & Forecast
12.3.2 Norway Pap Smear Test Market & Forecast
12.3.3 Norway HPV DNA Test Market & Forecast

13. Netherlands - Cervical Cancer Test Analysis
13.1 Netherlands Cervical Cancer Test (Screening) Population
13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast
13.2 Netherlands Cervical Cancer Mortality
13.3 Netherlands Cervical Cancer Test (Screening) Market
13.3.1 Netherlands Cervical Cancer Test Market & Forecast
13.3.2 Netherlands Pap Smear Test Market & Forecast
13.3.3 Netherlands HPV DNA Test Market & Forecast

14. Cervical Cancer Test Market Growth Drivers
14.1 Rising Cases of Teenage Sexual Cases Globally
14.2 Huge Prevalence of HPV Infected Patients Globally

15. Challenges in Cervical Cancer Test Market
15.1 Introduction of HPV Vaccination Programs Globally

List of Figures
Figure 2 1: Europe - Cervical Cancer Test Population (Million), 2008 - 2015
Figure 2 2: Europe - Forecast for Cervical Cancer Test Population (Million), 2016 - 2020
Figure 3 1: Europe - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 3 2: Europe - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 3 3: Europe - Cervical Cancer Pap Smear Test Market (Million US$), 2008 - 2015
Figure 3 4: Europe - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 - 2020
Figure 3 5: Europe - Cervical Cancer HPV DNA Test Market (Million US$), 2008 - 2015
Figure 3 6: Europe - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 - 2020
Figure 4 1: Europe - Cervical Cancer Test Population Share (Percent), 2008 - 2015
Figure 4 2: Europe - Forecast for Cervical Cancer Test Population Share (Percent), 2016 - 2020
Figure 4 3: Europe - Cervical Cancer Test Market Share (Percent), 2008 - 2015
Figure 4 4: Europe - Forecast for Cervical Cancer Test Market Share (Percent), 2016 - 2020
Figure 4 5: Europe - Cervical Cancer Pap Smear Test Market Share (Percent), 2008 - 2015
Figure 4 6: Europe - Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 - 2020
Figure 4 7: Europe - Cervical Cancer HPV DNA Test Market Share (Percent), 2008 - 2015
Figure 4 8: Europe - Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 - 2020
Figure 5 1: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 5 2: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 5 3: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 5 4: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 5 5: United Kingdom - Cervical Cancer Deaths (Number), 2001 - 2011
Figure 5 6: United Kingdom - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 5 7: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 5 8: United Kingdom - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 5 9: United Kingdom - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 5 10: United Kingdom - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 5 11: United Kingdom - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 6 1: France - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 6 2: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 6 3: France - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 6 4: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 6 5: France - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 6 6: France - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 6 7: France - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 6 8: France - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 6 9: France - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 6 10: France - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 6 11: France - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 7 1: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 7 2: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 7 3: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
Figure 7 4: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
Figure 7 5: Germany - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 7 6: Germany - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 7 7: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 7 8: Germany - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 7 9: Germany - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 7 10: Germany - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 7 11: Germany - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 8 1: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 8 2: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 8 3: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 8 4: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 8 5: Italy - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 8 6: Italy - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 8 7: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 8 8: Italy - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 8 9: Italy - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 8 10: Italy - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 8 11: Italy - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 9 1: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 9 2: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 9 3: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 9 4: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 -2020
Figure 9 5: Spain - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 9 6: Spain - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 9 7: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 9 8: Spain - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 9 9: Spain - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 9 10: Spain - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 9 11: Spain - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 10 1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 10 2: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 10 3: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 10 4: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 10 5: Sweden - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 10 6: Sweden - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 10 7: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 10 8: Sweden - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 10 9: Sweden - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 10 10: Sweden - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 10 11: Sweden - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 11 1: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 11 2: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 11 3: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 11 4: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 11 5: Switzerland - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 11 6: Switzerland - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 11 7: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 11 8: Switzerland - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 11 9: Switzerland - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 11 10: Switzerland - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 11 11: Switzerland - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 12 1: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 12 2: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 12 3: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 12 4: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 12 5: Norway - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 12 6: Norway - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 12 7: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 12 8: Norway - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 12 9: Norway - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 12 10: Norway - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 12 11: Norway - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020
Figure 13 1: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2008 - 2015
Figure 13 2: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 - 2020
Figure 13 3: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
Figure 13 4: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 - 2020
Figure 13 5: Netherlands - Cervical Cancer Mortality (Number), 2001 - 2011
Figure 13 6: Netherlands - Cervical Cancer Test Market (Million US$), 2008 - 2015
Figure 13 7: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2016 - 2020
Figure 13 8: Netherlands - Pap Smear Test Market (Million US$), 2008 - 2015
Figure 13 9: Netherlands - Forecast for Pap Smear Test Market (Million US$), 2016 - 2020
Figure 13 10: Netherlands - HPV DNA Test Market (Million US$), 2008 - 2015
Figure 13 11: Netherlands - Forecast for HPV DNA Test Market (Million US$), 2016 - 2020

List of Tables
Table 25 3: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
Table 25 4: Worldwide - HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010

Note: Product cover images may vary from those shown
3 of 3

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll